Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Archives of Osteoporosis
Published in: Archives of Osteoporosis 1-2/2013

01-12-2013 | Original Article

Health care costs of osteopenia, osteoporosis, and fragility fractures in Mexico

Authors: Fernando Carlos, Patricia Clark, Rosa María Galindo-Suárez, Laura Gabriela Chico-Barba

Published in: Archives of Osteoporosis | Issue 1-2/2013

Login to get access

Abstract

Summary

Different sources were used to estimate the 2010 health care costs of managing low bone density (osteopenia/osteoporosis) plus caring fragility fractures in Mexico at 411 million USD. Figures are projected to rise 42 % by 2020. Preventive and timely interventions are required to decrease the financial burden of these entities.

Introduction

Osteopenia, osteoporosis, and fragility fractures (FF) are a public health concern. The study purpose was to estimate the health care costs of these conditions in Mexico during 2010 and project them to 2015 and 2020.

Methods

Prevalence of osteopenia and osteoporosis was derived from international data. The Mexican version of FRAX® algorithm was used to assess risk for a major FF (hip, clinical spine, forearm, and proximal humerus) in osteopenic and osteoporotic population aged over 40 years. The estimates were applied to national demographic projections. Only direct medical costs composed by routine non-pharmacological management of osteopenia/osteoporosis besides the costs owing to medical care of major FF were considered into the analysis. Resource use for managing osteopenia/osteoporosis was defined from local sources (clinical practice guidelines, published literature, and expert opinion); unit costs were gathered from official lists. Costs for medical care of FF were based on diagnosis-related groups.

Results

In population aged ≥40 years, prevalence of osteopenia and osteoporosis in 2010 was 32.8 and 8 %, respectively. A total of 75,763 FF occurred that year. Costs of managing osteopenia and osteoporosis were 154.9 million USD, whereas medical costs due to FF reached 256.2 million USD. Therefore, the annual health care costs of these entities in 2010 were 411 million USD. Total costs will be 19.2 % higher in 2015, and by 2020, the figures will have increased by 41.7 %.

Conclusions

Low bone density entails substantial epidemiological and financial burden in Mexico, and their impact will grow considerably during the next years.
Literature
1.
Anonymous (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129
2.
3.
Looker AC, Melton LJ 3rd, Harris TB, Borrud LG, Shepherd JA (2010) Prevalence and trends in low femur bone density among older US adults: NHANES 2005–2006 compared with NHANES III. J Bone Miner Res 25(1):64–71PubMedCrossRef
4.
Lewiecki EM (2008) Prevention and treatment of postmenopausal osteoporosis. Obstet Gynecol Clin North Am 35:301–315PubMedCrossRef
5.
Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301(5):513–521PubMedCrossRef
6.
Vestergaard P, Rejnmark L, Mosekilde L (2009) Loss of life years after a hip fracture. Acta Orthop 80:525–530PubMedCrossRef
7.
Peasgood T, Herrmann K, Kanis JA, Brazier JE (2009) An updated systematic review of Health State Utility Values for osteoporosis related conditions. Osteoporos Int 20:853–868PubMedCrossRef
8.
Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733PubMedCrossRef
9.
Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16(Suppl 2):S3–S7PubMedCrossRef
10.
Foundation NO (2008) Clinician’s guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC
11.
Becker DJ, Kilgore ML, Morrisey MA (2010) The societal burden of osteoporosis. Curr Rheumatol Rep 12:186–191PubMedCrossRef
12.
Tarricone R (2006) Cost-of-illness analysis. What room in health economics? Health Policy 77:51–63PubMedCrossRef
13.
Clark P, Carlos F, Vazquez-Martinez JL (2010) Epidemiology, costs and burden of osteoporosis in Mexico. Arch Osteoporos 5:9–17CrossRef
14.
Cruz GI, Cisneros DF, Salazar PR, Tejeida LA (2002) Costos institucionales y dificultades en la atención de los pacientes con fracturas por osteoporosis. Acta Ortop Mex 16:292–295
15.
Velasco-Murillo V, Navarrete-Hernández E, Pozos-Cavanzo JL, Ojeda-Mijares RI, Camacho-Rodríguez MA (2003) Fracturas en mujeres postmenopáusicas en el IMSS: frecuencia y costos de su atención hospitalaria. Gac Med Mex 139:453–458PubMed
16.
Clark P, Carlos F, Barrera C, Guzman J, Maetzel A, Lavielle P, Ramirez E, Robinson V, Rodriguez-Cabrera R, Tamayo J, Tugwell P (2008) Direct costs of osteoporosis and hip fracture: an analysis for the Mexican healthcare system. Osteoporos Int 19:269–276PubMedCrossRef
17.
Carlos F, Clark P, Maciel H, Tamayo JA (2009) Direct costs of osteoporosis and hip fracture: an analysis for the Mexican Social Insurance Health Care System. Salud Publica Mex 51(suppl 1):S108–S113PubMed
18.
19.
Instituto Nacional de Estadística y Geografía. Encuesta Nacional de Empleo y Seguridad Social (2009) Aguascalientes, Ags. México 2010
20.
Kanis JA, on behalf of the World Health Organization Scientific Group (2007) Assessment of osteoporosis at the primary health-care level. Technical report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield. University of Sheffield, UK
21.
Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N, Cauley JA, Compston JE, Dawson-Hughes B, El-Hajj Fuleihan G, Johansson H, Leslie WD, Lewiecki EM, Luckey M, Oden A, Papapoulos SE, Poiana C, Rizzoli R, Wahl DA, McCloskey EV, Task Force of the FRAX Initiative (2011) Interpretation and use of FRAX in clinical practice. Osteoporos Int 22:2395–2411PubMedCrossRef
22.
Stevenson M, Davis S, Lloyd-Jones M, Beverley C (2007) The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women. Health Technol Assess 11:1–134PubMed
23.
Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Glüer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ 3rd, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046PubMedCrossRef
24.
Briggs A, Sculpher M (1998) An introduction to Markov modelling for economic evaluation. PharmacoEconomics 13:397–409PubMedCrossRef
25.
Ettinger B, Black DM, Dawson-Hughes B, Pressman AR, Melton LJ 3rd (2010) Updated fracture incidence rates for the US version of FRAX. Osteoporos Int 21:25–33PubMedCentralPubMedCrossRef
26.
Instituto Mexicano del Seguro Social. Guía de Referencia Rápida (2009) Diagnóstico y Tratamiento de la Osteoporosis en el Adulto. Instituto Mexicano del Seguro Social, Guía de Referencia Rápida, Mexico City
27.
Sistema de Protección Social en Salud (2005) Elementos conceptuales, económicos y operativos. En: Unidad de Análisis Económico, Primerath edn. Secretaria de Salud, México, pp 11–38
28.
Instituto Mexicano del Seguro Social. Costos Unitarios de Atención Médica. Diario Oficial de la Federación. Martes 18 de mayo de 2010
29.
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado. Informe Financiero y Actuarial (2010) México, D.F., junio de 2010
30.
Instituto Nacional de Rehabilitación (2010) Tabulador de costos de recuperación. Secretaría de Salud, México
31.
32.
33.
Mueller D, Gandjour A (2009) Cost-effectiveness of using clinical risk factors with and without DXA for osteoporosis screening in postmenopausal women. Value Health 12:1106–1117PubMedCrossRef
34.
35.
Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475PubMedCrossRef
36.
Shi N, Foley K, Lenhart G, Badamgarav E (2009) Direct healthcare costs of hip, vertebral, and non-hip, non-vertebral fractures. Bone 45(6):1084–1090PubMedCrossRef
37.
Kanis JA, McCloskey EV, Johansson H, Oden A, Ström O, Borgström F (2010) Development and use of FRAX in osteoporosis. Osteoporos Int 21(Suppl 2):S407–S413PubMedCrossRef
38.
Dilla T, Sacristán JA, Rentero ML (2007) Evaluación económica de teriparatida (forsteo®) en el tratamiento de la osteoporosis posmenopáusica. Rev Esp Econ Salud 6(1):57–64
39.
Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET (2010) Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. PharmacoEconomics 28(5):395–409PubMedCrossRef
40.
Tarride JE, Hopkins RB, Leslie WD, Morin S, Adachi JD, Papaioannou A, Bessette L, Brown JP, Goeree R (2012) The burden of illness of osteoporosis in Canada. Osteoporos Int. doi:10.​1007/​s00198-012-1931-z
Metadata
Title
Health care costs of osteopenia, osteoporosis, and fragility fractures in Mexico
Authors
Fernando Carlos
Patricia Clark
Rosa María Galindo-Suárez
Laura Gabriela Chico-Barba
Publication date
01-12-2013
Publisher
Springer London
Published in
Archives of Osteoporosis / Issue 1-2/2013
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-013-0125-4

Other articles of this Issue 1-2/2013

Archives of Osteoporosis 1-2/2013 Go to the issue

Original Article

Development and application of FRAX in the management of osteoporosis in Ireland

Original Article

Hand grip strength and its correlation with vitamin D in Indian patients with hip fracture

Original Article

Concern and risk perception of osteoporosis and fracture among post-menopausal Australian women: results from the Global Longitudinal Study of Osteoporosis in Women (GLOW) cohort

Original Article

Sri Lankan FRAX model and country-specific intervention thresholds

Original Article

Low bone mineral density is associated with metabolic syndrome in South Korean men but not in women: The 2008–2010 Korean National Health and Nutrition Examination Survey

Original Article

Testing for vitamin D and other trends in the clinical management of osteoporosis